PAPER Finckh U, von der Kammer H, Velden J, Michel T, Andresen B, Deng A, Zhang J, Müller-Thomsen T, Zuchowski K, Menzer G, Mann U, Papassotiropoulos A, Heun R, Zurdel J, Holst F, Benussi L, Stoppe G, Reiss J, Miserez AR, Staehelin HB, Rebeck GW, Hyman BT, Binetti G, Hock C, Growdon JH, Nitsch RM
SEARCH RESULTS
345087 RESULTS
PAPER Broe GA, Grayson DA, Creasey HM, Waite LM, Casey BJ, Bennett HP, Brooks WS, Halliday GM
Anti-inflammatory drugs protect against Alzheimer disease at low doses.
Arch Neurol. 2000 Nov;57(11):1586-91. PubMed.PAPER Bennett DA
Alzheimer's disease--introduction
Dis Mon. 2000 Oct;46(10):653-6. PubMed.PAPER Balbach JJ, Ishii Y, Antzutkin ON, Leapman RD, Rizzo NW, Dyda F, Reed J, Tycko R
Amyloid fibril formation by A beta 16-22, a seven-residue fragment of the Alzheimer's beta-amyloid peptide, and structural characterization by solid state NMR.
Biochemistry. 2000 Nov 14;39(45):13748-59. PubMed.PAPER Mah AL, Perry G, Smith MA, Monteiro MJ
Identification of ubiquilin, a novel presenilin interactor that increases presenilin protein accumulation.
J Cell Biol. 2000 Nov 13;151(4):847-62. PubMed.PAPER Bennett DA
Part I. Epidemiology and public health impact of Alzheimer's disease.
Dis Mon. 2000 Oct;46(10):657-65. PubMed.PAPER Giri R, Shen Y, Stins M, Du Yan S, Schmidt AM, Stern D, Kim KS, Zlokovic B, Kalra VK
beta-amyloid-induced migration of monocytes across human brain endothelial cells involves RAGE and PECAM-1.
Am J Physiol Cell Physiol. 2000 Dec;279(6):C1772-81. PubMed.PAPER Marsh GW, Prochoda KP, Pritchett E, Vojir CP
Predicting hospice appropriateness for patients with dementia of the Alzheimer's type.
Appl Nurs Res. 2000 Nov;13(4):187-96. PubMed.PAPER Hoffman JM, Welsh-Bohmer KA, Hanson M, Crain B, Hulette C, Earl N, Coleman RE
FDG PET imaging in patients with pathologically verified dementia.
J Nucl Med. 2000 Nov;41(11):1920-8. PubMed.PAPER Silverman DH, Phelps ME
Evaluating dementia using PET: how do we put into clinical perspective what we know to date?
J Nucl Med. 2000 Nov;41(11):1929-32. PubMed.PAPER Houlden H, Baker M, McGowan E, Lewis P, Hutton M, Crook R, Wood NW, Kumar-Singh S, Geddes J, Swash M, Scaravilli F, Holton JL, Lashley T, Tomita T, Hashimoto T, Verkkoniemi A, Kalimo H, Somer M, Paetau A, Martin JJ, Van Broeckhoven C, Golde T, Hardy J, Haltia M, Revesz T
Variant Alzheimer's disease with spastic paraparesis and cotton wool plaques is caused by PS-1 mutations that lead to exceptionally high amyloid-beta concentrations.
Ann Neurol. 2000 Nov;48(5):806-8. PubMed.PAPER Praticò D, Clark CM, Lee VM, Trojanowski JQ, Rokach J, FitzGerald GA
Increased 8,12-iso-iPF2alpha-VI in Alzheimer's disease: correlation of a noninvasive index of lipid peroxidation with disease severity.
Ann Neurol. 2000 Nov;48(5):809-12. PubMed.PAPER Minster RL, Dekosky ST, Ganguli M, Belle S, Kamboh MI
Genetic association studies of interleukin-1 (IL-1A and IL-1B) and interleukin-1 receptor antagonist genes and the risk of Alzheimer's disease.
Ann Neurol. 2000 Nov;48(5):817-9. PubMed.PAPER Lopez MF, Kristal BS, Chernokalskaya E, Lazarev A, Shestopalov AI, Bogdanova A, Robinson M
High-throughput profiling of the mitochondrial proteome using affinity fractionation and automation.
Electrophoresis. 2000 Oct;21(16):3427-40. PubMed.PAPER Toliver-Kinsky T, Wood T, Perez-Polo JR
Nuclear factor kappaB/p49 is a negative regulatory factor in nerve growth factor-induced choline acetyltransferase promoter activity in PC12 cells.
J Neurochem. 2000 Dec;75(6):2241-51. PubMed.Current Filters
No filters selected